KURA – Kura Oncology, Inc.
KURA — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
17.91
Margin Of Safety %
Put/Call OI Ratio
0.08
EPS Next Q Diff
-0.1
EPS Last/This Y
-0.34
EPS This/Next Y
0.97
Price
11.22
Target Price
31.17
Analyst Recom
1.2
Performance Q
34.73
Upside
-1,142.2%
Beta
0.36
Ticker: KURA
21 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-24 | KURA | 9.27 | 0.25 | 0.15 | 4993 |
| 2026-04-27 | KURA | 9.08 | 0.24 | 0.36 | 5932 |
| 2026-04-28 | KURA | 8.84 | 0.24 | 0.12 | 6076 |
| 2026-04-29 | KURA | 8.76 | 0.24 | 7.55 | 6211 |
| 2026-04-30 | KURA | 8.85 | 0.31 | 0.91 | 6535 |
| 2026-05-01 | KURA | 8.78 | 0.31 | 1.71 | 6552 |
| 2026-05-04 | KURA | 9.24 | 0.31 | 0.03 | 6568 |
| 2026-05-05 | KURA | 9.3 | 0.29 | 0.60 | 7031 |
| 2026-05-06 | KURA | 9.56 | 0.29 | 0.23 | 7118 |
| 2026-05-07 | KURA | 9.35 | 0.29 | 0.08 | 7122 |
| 2026-05-08 | KURA | 9.42 | 0.29 | 0.09 | 7113 |
| 2026-05-11 | KURA | 9.52 | 0.28 | 0.10 | 7342 |
| 2026-05-12 | KURA | 9.66 | 0.27 | 0.03 | 7466 |
| 2026-05-13 | KURA | 9.49 | 0.27 | 0.06 | 7626 |
| 2026-05-14 | KURA | 9.75 | 0.26 | 0.04 | 7660 |
| 2026-05-15 | KURA | 9.23 | 0.26 | 0.32 | 7696 |
| 2026-05-18 | KURA | 9.21 | 0.20 | 0.92 | 4244 |
| 2026-05-19 | KURA | 8.94 | 0.23 | 0.09 | 4402 |
| 2026-05-20 | KURA | 10.34 | 0.17 | 0.01 | 5502 |
| 2026-05-21 | KURA | 11.14 | 0.11 | 0.07 | 7824 |
| 2026-05-22 | KURA | 11.22 | 0.08 | 0.08 | 11406 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-24 | KURA | 9.27 | -17.5 | -41.9 | -3.43 |
| 2026-04-27 | KURA | 9.08 | -17.5 | -14.0 | -3.43 |
| 2026-04-28 | KURA | 8.84 | -17.5 | -4.8 | -3.43 |
| 2026-04-30 | KURA | 8.83 | -17.5 | -60.7 | -3.43 |
| 2026-05-01 | KURA | 8.77 | -17.5 | -32.4 | -3.43 |
| 2026-05-04 | KURA | 9.25 | -17.5 | -149.7 | -3.43 |
| 2026-05-05 | KURA | 9.28 | -17.5 | -51.9 | -3.43 |
| 2026-05-06 | KURA | 9.56 | -17.5 | -91.1 | -3.43 |
| 2026-05-07 | KURA | 9.35 | -17.5 | -14.8 | -3.43 |
| 2026-05-08 | KURA | 9.42 | -17.5 | -58.7 | -3.43 |
| 2026-05-11 | KURA | 9.51 | -17.5 | -59.5 | -3.43 |
| 2026-05-12 | KURA | 9.66 | -17.5 | -66.1 | -3.43 |
| 2026-05-13 | KURA | 9.48 | -17.5 | -18.8 | -3.43 |
| 2026-05-14 | KURA | 9.76 | -17.5 | -55.7 | -3.43 |
| 2026-05-15 | KURA | 9.22 | -17.5 | 3.8 | -3.43 |
| 2026-05-18 | KURA | 9.21 | -17.5 | -47.0 | -3.51 |
| 2026-05-19 | KURA | 8.95 | -17.5 | -18.1 | -3.51 |
| 2026-05-20 | KURA | 10.33 | -17.5 | -223.6 | -3.52 |
| 2026-05-21 | KURA | 11.14 | -17.5 | -114.3 | -3.52 |
| 2026-05-22 | KURA | 11.22 | -20.8 | -54.8 | -3.52 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-24 | KURA | -4.09 | 1.23 | 16.58 |
| 2026-04-27 | KURA | -4.07 | -0.21 | 17.44 |
| 2026-04-28 | KURA | -4.07 | -0.21 | 17.44 |
| 2026-04-29 | KURA | -4.07 | -0.21 | 17.44 |
| 2026-04-30 | KURA | -4.07 | -0.21 | 17.44 |
| 2026-05-01 | KURA | -4.07 | -0.21 | 17.44 |
| 2026-05-04 | KURA | -4.07 | 0.09 | 17.35 |
| 2026-05-05 | KURA | -4.87 | 0.09 | 17.35 |
| 2026-05-06 | KURA | -4.87 | 0.09 | 17.35 |
| 2026-05-07 | KURA | -4.87 | 0.09 | 17.35 |
| 2026-05-08 | KURA | -4.87 | 0.09 | 17.35 |
| 2026-05-11 | KURA | -4.87 | -1.26 | 17.35 |
| 2026-05-12 | KURA | -4.87 | -1.26 | 17.84 |
| 2026-05-13 | KURA | -4.87 | -1.26 | 17.84 |
| 2026-05-14 | KURA | -4.87 | -1.26 | 17.84 |
| 2026-05-15 | KURA | -3.03 | -1.26 | 17.83 |
| 2026-05-18 | KURA | -3.03 | -0.98 | 17.83 |
| 2026-05-19 | KURA | -3.04 | -0.98 | 17.91 |
| 2026-05-20 | KURA | -2.58 | -0.98 | 17.91 |
| 2026-05-21 | KURA | -2.75 | -0.98 | 17.91 |
| 2026-05-22 | KURA | -2.75 | -0.98 | 17.91 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.83
Avg. EPS Est. Current Quarter
-0.91
Avg. EPS Est. Next Quarter
-0.93
Insider Transactions
-2.75
Institutional Transactions
-0.98
Beta
0.36
Average Sales Estimate Current Quarter
19
Average Sales Estimate Next Quarter
22
Fair Value
Quality Score
36
Growth Score
27
Sentiment Score
97
Actual DrawDown %
53.9
Max Drawdown 5-Year %
-76.5
Target Price
31.17
P/E
Forward P/E
PEG
P/S
13.94
P/B
9.26
P/Free Cash Flow
EPS
-3.35
Average EPS Est. Cur. Y
-3.52
EPS Next Y. (Est.)
-2.55
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-411.19
Relative Volume
1.59
Return on Equity vs Sector %
-300.1
Return on Equity vs Industry %
-284.5
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.17
EBIT Estimation
-54.8
◆
KURA
Healthcare
$11.25
📉
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
4/25
Volume
0/15
Valuation
9/20
TP/AR
2/10
Options
8/10
RSI
71.5
Range 1M
89%
Sup Dist
7.6%
🚀
Momentum Growth
Ride accelerating trends
WEAK
Momentum
19/25
Growth
14/30
Estimates
0/20
Inst/Vol
7/15
Options
8/10
EPS Yr
-11.5%
EPS NY
25.5%
52W%
81.5%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+177.1% upside
Quality
7/30
Valuation
15/30
Growth
10/25
Stability
7/10
LT Trend
4/5
Upside
+177.1%
Quality
36
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Biotechnology
Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
KURA
Latest News
—
Caricamento notizie per KURA…
stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today
news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance
stock history KURA – Kura Oncology, Inc. invest stock market
stock prices KURA premarket after hours
ticker KURA fair value insiders trading